Invus Global Management, LLC - 29 Aug 2025 SCHEDULE 13G Report for vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share (VTVT)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Raymond Debbane
Security
vTv Therapeutics Inc. Class A Common Stock, $0.01 par value per share
Symbol
VTVT
Shares outstanding
3,484,314 shares
Disclosed Ownership
348,083 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
08 Sep 2025, 17:43:43 UTC
Date of event
29 Aug 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 8.8% 306,313 306,313 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 8.8% 306,313 306,313 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 8.8% 306,313 306,313 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 8.8% 306,313 306,313 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 1.3% 41,770 41,770 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 1.3% 41,770 41,770 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Ulys, L.L.C. 1.3% 41,770 41,770 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 10% 348,083 348,083 0 /s/ Raymond Debbane Raymond Debbane